Glazer Capital’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Glazer Capital's IBER.U Position: Q1 2023 in Review
Glazer Capital sold out of Ibere Pharmaceuticals Units (IBER.U) in Q1 2023, closing a stake of 1,000 shares — an estimated $10K sold.
Glazer Capital first reported a position in IBER.U in Q1 2021 and held it in 7 quarters. The position peaked at $3.46M in Q1 2021. 0 funds tracked by Wall St. Rank hold IBER.U as of Q1 2023.
- Glazer Capital reported no remaining Ibere Pharmaceuticals Units position as of Q1 2023 after selling out during the quarter.
- Glazer Capital sold 1,000 Ibere Pharmaceuticals Units shares in Q1 2023, an estimated $10K.
- Glazer Capital first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 7 quarters.
- Glazer Capital's Ibere Pharmaceuticals Units position peaked at $3.46M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q1 2023.
Based on Glazer Capital's 13F filing for Q1 2023, filed 15 May 2023.